FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965532261> ?p ?o ?g. }

• W1965532261 endingPage "550" @default.
• W1965532261 startingPage "550" @default.
• W1965532261 abstract "Positive results are reported from a double-blind study of estrogen therapy administered to severely depressed, inpatient women who had failed to respond to various conventional treatments of depression. Large doses of oral conjugated estrogen were administered for a three-month period to 23 premenopausal and postmenopausal inpatient women. Placebos were administered for a comparable period to 17 similar patients. The posttreatment Hamilton ratings of depression were significantly reduced in the estrogen-treated group, but not in the placebo group. Possible physiological mechanisms are discussed. The risk-benefit ratio for estrogen therapy of depression in these patients was judged to be favorable. However, periodic endometrial biopsies are required to monitor the endometrial response of women receiving high doses of estrogens.The effectiveness of estrogen therapy for alleviating severe depressions was investigated in a double blind study in which large doses of estrogen were administered to 15 premenopausal and 8 postmenopausal women and placebos were administered to 12 premenopausal and 5 postmenopausal women. The estrogens and placebos were administered over a three month period, and the women were blind rated each week by psychologists and psychiatrists using Hamilton rating scales for depression. There was a significant decline in the depression scores for the group treated with estrogens when compared to the placebo treated group. Considerable variation in the degree of improvement for the women in the estrogen treated group was observed. These variations were not related to age or to menstrual status but were significantly related to depression duration. Women with shorter histories of depression were more likely to show improvement than women with longer illness durations. Efforts were also made to understand the physiological mechanisms through which estrogen treatment contributed toward reducing depression. Previous studies revealed that decreased availability of norepinephrine at the central adrenegic receptor sites in the brain was related to the manifestation of depression while increased availability of norepinephrine at these sites was ralated to a manifestation of elation. Increased availability of norepinephrine has been shown to be related to an inhibition of monoamine oxidase activity (MAO), and estrogen, in turn, has been demonstrated to inhibit MAO activity. During the 3 month study period, 2 blood samples were obtained from the women every week and analyzed for MAO activity. All patients had elevated levels of plasma MAO activity prior to treatment. In estrogen treated patients, MAO levels declined significantly; MAO levels unexplicably increased for the placebo treated group. Reduced MAO activity was not, however, significantly correlated with lower depression ratings. In determining the risk/benefit ratio of estrogen therapy both the risk of developing endometrial cancer and the risks of life long disability and suicide stemming from severe depression should be considered. Tables show 1) mean depression ratings and average MAO activity levels before and after treatment for the estrogen and placebo treated groups and 2) degree of change in depression ratings before and after treatment for both groups of women." @default.
• W1965532261 created "2016-06-24" @default.
• W1965532261 creator A5071031030 @default.
• W1965532261 date "1979-05-01" @default.
• W1965532261 modified "2023-10-14" @default.
• W1965532261 title "Estrogen Therapy for Severe Persistent Depressions in Women" @default.
• W1965532261 cites W1574464433 @default.
• W1965532261 cites W1910242855 @default.
• W1965532261 cites W1966227815 @default.
• W1965532261 cites W1978001796 @default.
• W1965532261 cites W1978012827 @default.
• W1965532261 cites W1982769548 @default.
• W1965532261 cites W2001979716 @default.
• W1965532261 cites W2002462727 @default.
• W1965532261 cites W2010928336 @default.
• W1965532261 cites W2013553899 @default.
• W1965532261 cites W2020844317 @default.
• W1965532261 cites W2028761342 @default.
• W1965532261 cites W2065159546 @default.
• W1965532261 cites W2067391489 @default.
• W1965532261 cites W2068178626 @default.
• W1965532261 cites W2072219714 @default.
• W1965532261 cites W2087962260 @default.
• W1965532261 cites W2114613490 @default.
• W1965532261 cites W2288628880 @default.
• W1965532261 cites W2314604683 @default.
• W1965532261 cites W2321712742 @default.
• W1965532261 cites W2336212480 @default.
• W1965532261 cites W2403865241 @default.
• W1965532261 cites W2490887606 @default.
• W1965532261 cites W2554257214 @default.
• W1965532261 cites W2992142921 @default.
• W1965532261 doi "https://doi.org/10.1001/archpsyc.1979.01780050060006" @default.
• W1965532261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/219802" @default.
• W1965532261 hasPublicationYear "1979" @default.
• W1965532261 type Work @default.
• W1965532261 sameAs 1965532261 @default.
• W1965532261 citedByCount "339" @default.
• W1965532261 countsByYear W19655322612013 @default.
• W1965532261 countsByYear W19655322612014 @default.
• W1965532261 countsByYear W19655322612015 @default.
• W1965532261 countsByYear W19655322612016 @default.
• W1965532261 countsByYear W19655322612017 @default.
• W1965532261 countsByYear W19655322612019 @default.
• W1965532261 countsByYear W19655322612022 @default.
• W1965532261 crossrefType "journal-article" @default.
• W1965532261 hasAuthorship W1965532261A5071031030 @default.
• W1965532261 hasConcept C126322002 @default.
• W1965532261 hasConcept C139719470 @default.
• W1965532261 hasConcept C142724271 @default.
• W1965532261 hasConcept C162324750 @default.
• W1965532261 hasConcept C204787440 @default.
• W1965532261 hasConcept C27081682 @default.
• W1965532261 hasConcept C2776867660 @default.
• W1965532261 hasConcept C2777164284 @default.
• W1965532261 hasConcept C3020687571 @default.
• W1965532261 hasConcept C42407357 @default.
• W1965532261 hasConcept C71924100 @default.
• W1965532261 hasConceptScore W1965532261C126322002 @default.
• W1965532261 hasConceptScore W1965532261C139719470 @default.
• W1965532261 hasConceptScore W1965532261C142724271 @default.
• W1965532261 hasConceptScore W1965532261C162324750 @default.
• W1965532261 hasConceptScore W1965532261C204787440 @default.
• W1965532261 hasConceptScore W1965532261C27081682 @default.
• W1965532261 hasConceptScore W1965532261C2776867660 @default.
• W1965532261 hasConceptScore W1965532261C2777164284 @default.
• W1965532261 hasConceptScore W1965532261C3020687571 @default.
• W1965532261 hasConceptScore W1965532261C42407357 @default.
• W1965532261 hasConceptScore W1965532261C71924100 @default.
• W1965532261 hasIssue "5" @default.
• W1965532261 hasLocation W19655322611 @default.
• W1965532261 hasLocation W19655322612 @default.
• W1965532261 hasOpenAccess W1965532261 @default.
• W1965532261 hasPrimaryLocation W19655322611 @default.
• W1965532261 hasRelatedWork W1278354262 @default.
• W1965532261 hasRelatedWork W1984291702 @default.
• W1965532261 hasRelatedWork W1995647897 @default.
• W1965532261 hasRelatedWork W2025970307 @default.
• W1965532261 hasRelatedWork W2109882125 @default.
• W1965532261 hasRelatedWork W2168803779 @default.
• W1965532261 hasRelatedWork W2425280638 @default.
• W1965532261 hasRelatedWork W2472708506 @default.
• W1965532261 hasRelatedWork W4233016836 @default.
• W1965532261 hasRelatedWork W2279599896 @default.
• W1965532261 hasVolume "36" @default.
• W1965532261 isParatext "false" @default.
• W1965532261 isRetracted "false" @default.
• W1965532261 magId "1965532261" @default.
• W1965532261 workType "article" @default.